Structural Requirements for CNS Active Opioid Glycopeptides.

Area of Science:

• Neuroscience
• Pharmacology
• Biochemistry

Background:

• Opioid peptides, such as beta-endorphin, are known for their analgesic properties.
• The blood-brain barrier (BBB) limits the central nervous system (CNS) access of many potential therapeutics.
• Glycosylation is explored as a strategy to enhance BBB penetration of peptide drugs.

Purpose of the Study:

• To synthesize and evaluate glycopeptides related to beta-endorphin for their ability to cross the BBB and produce antinociception.
• To investigate the structural requirements, particularly amphipathic helices, for antinociceptive activity.
• To assess the opioid receptor binding affinity and selectivity of novel glycopeptide analogues.

Main Methods:

• Synthesis of two series of glycopeptides based on opioid structures.
• Assessment of opioid receptor binding affinity.
• Evaluation of antinociceptive activity using the 55°C tail flick test in mice.
• Structural analysis using Circular Dichroism (CD) spectroscopy in various environments (H2O, TFE, SDS micelles).
• Nuclear Magnetic Resonance (NMR) spectroscopy (600 MHz) including Chemical Shift Indices (CSI) and Nuclear Overhauser Effects (NOE).
• Molecular dynamics calculations to rationalize observed structures.

Main Results:

• Glycopeptides related to beta-endorphin demonstrated penetration of the mouse BBB, leading to antinociception.
• Attempts to enhance mu-selectivity in DAMGO-related glycopeptides by altering charged residues were unsuccessful.
• A flexible linker was found to be essential for maintaining antinociceptive activity.
• CD and NMR studies confirmed the importance of amphipathic helical structures in micelles for activity, while glycosylated analogues showed less defined structures in aqueous solutions.
• Molecular dynamics supported the helical conformations in micelles.

Conclusions:

• Glycosylated endorphin analogues are promising drug candidates for pain management due to their ability to penetrate the BBB.
• The study highlights the critical role of specific structural features, like amphipathic helices within micelles, for central antinociceptive effects.
• Further development of these glycosylated peptides could lead to novel CNS-acting analgesics.